Trial Code
Ages
Location
Gender
Ethnicity
Payment
Nicotine Restrictions
Duration of stay
Summary
- We are conducting a participant engagement study for adults aged 18 years and above with confirmed or suspected Factor V Leiden or Prothrombin G20210A mutation (mutations that increase the risk for blood clots).
- The study aims to provide participants with the opportunity to familiarise themselves with the clinical trial environment and to establish a baseline health status prior to considering participation in related future clinical trials.
- You will be reimbursed for your time.
If you are interested in participating in this participant engagement study:
- You will need to attend an in-person Screening Visit, during which the study will be given an overview of the study, and you will be asked to provide informed consent.
- If you have not previously had genetic testing, a blood sample will be taken at the Screening Visit to confirm the presence of FVL or prothrombin G20210A mutation.
- You will need to attend an in-person Participant Engagement Visit (Day 1), where you will undergo assessments to establish your baseline health status (including vital signs, heart function check, and physical examination) and be given a tour of the clinical trials unit. If available, you will also receive information regarding upcoming related clinical trials to take home.
- If you have previously had genetic testing, the Patient Engagement Visit (Day 1) will occur on the same day as the Screening Visit.
- About one week after the Participant Engagement Visit, you will have a Telephone Follow-Up call with the Study Doctor to discuss any findings from the assessments and address any questions.
- If some results are not yet available at the time of this call, you may receive an additional Telephone Follow-Up to review those results once they become available.
Who can take part
We will check your suitability for the study using the following criteria:
- You are a male or female and aged 18 years and above.
- You have been diagnosed with, or are suspected of, having Factor V Leiden or Prothrombin G20210A mutation.
- You are able and willing to provide informed consent, and to comply with study tests and procedures.
A member of our recruitment team will give you a full list of do’s and don’ts if you are interested.
Payment
In recognition of the time and effort involved in taking part in the study, you will receive up to £500 on completion of the study (if you receive two telephone follow-up calls), provided you comply fully with all the study requirements. Reasonable travel expenses (up to £45) may be reimbursed with valid receipts. Any additional required visits will be paid for accordingly.
Dates
Overall, the study process will take approximately 15 weeks; however, additional assessments/visits may be performed over a period of up to 12 months. You will be required to come to the clinical trial unit at least once.
You will only be required to stay in the clinic for one of the above admission periods.
Contact Us for More Information
Email: volunteer@richmondpharmacology.com
Call us: Mon - Fri between 09h00 and 17h00 on +44 (0) 207 042 5802 to speak to a member of our Volunteer Recruitment Team.
Approval
The contents of this document have been approved by an Ethics Committee. Any response to this advertisement will be recorded. Your response will not place you under any obligation to participate in this trial.
Ref: C25049_Mar-2026 (email_website_advert text)
